dactinomycin has been researched along with cyclosporine in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (48.72) | 18.2507 |
| 2000's | 11 (28.21) | 29.6817 |
| 2010's | 8 (20.51) | 24.3611 |
| 2020's | 1 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Smyth, MJ | 1 |
| Norihisa, Y; Ortaldo, JR; Smyth, MJ | 1 |
| Gollapudi, S; Gupta, S; Tsuruo, T | 1 |
| Borger, P; Dokter, WH; Halie, MR; Hendriks, D; van der Horst, I; Vellenga, E | 1 |
| Evans, GA; Farrar, WL; Wahl, LM | 1 |
| Malkovsky, M; Manning, JK; Meager, A | 1 |
| Hata, D; Heike, T; Higaki, Y; Horiguchi, Y; Ishigami, T; Katamura, K; Kim, KM; Mayumi, M; Mikawa, H | 1 |
| Antoniadis, A; Christodoulou, D; Dimitriadou, A; Exindari, M; Haitoglou, K; Malissiovas, N; Trakatellis, A | 1 |
| Jenkins, MK; Mondino, A | 1 |
| Marakhova, II; Toropova, FV; Vereninov, AA; Vinogradova, TA | 1 |
| Bates, SE; Dickstein, B; Fojo, AT; Lee, JS; Spolyar, M | 1 |
| Cowie, F; Pinkerton, CR | 1 |
| Heitman, J; Hemenway, CS | 1 |
| Arron, J; Choi, Y; Wong, B | 1 |
| Chan, HS; Doyle, J; Greenberg, ML; Karaskov, V; Koren, G; Malkin, D; Moncica, I; Theis, JG | 2 |
| Billah, MM; Egan, RW; Nahrebne, DK; Razac, S; Shah, H; Umland, SP | 1 |
| Ishaq, M; Natarajan, V; Zhang, YM | 1 |
| Cosimi, AB; Ingelfinger, JR; Pascual, M; Swinford, RD; Tolkoff-Rubin, N; Williams, WW | 1 |
| Chi, JG; Cho, SS; Choi, EY; Chung, DH; Hwang, DH; Jang, JJ; Jun, BH; Kim, SH; Lee, IS; Park, SH; Sohn, HW; Sung, UA | 1 |
| Okunuki, H; Onose, J; Sawada, J; Teshima, R | 1 |
| Gierman, JL; Jaligam, VR; Kantrow, SP; Lancaster, JR; Piantadosi, CA; Summer, WR; Zhang, P | 1 |
| Mitchell, JB; Smith, J | 1 |
| Basinger, SF; Le, WD; Wu, SM; Yang, CY; Yang, JH | 1 |
| Adams, V; Barten, MJ; Boldt, A; Dhein, S; Gummert, JF; Mohr, FW; Sagner, A | 1 |
| Manna, SK; Raghavendra, PB; Ramesh, GT; Sreenivasan, Y | 1 |
| Goodisman, J; Jones, E; Souid, AK; Tao, Z | 1 |
| Bryne, M; Halstensen, TS; Husvik, C | 1 |
| Del Rosso, JQ; Momin, SB; Peterson, A | 1 |
| Edlich, F; Falquez-Medina, H; Fimm-Todt, F; Funk, K; Jahreis, G; Klesse, R; Lauterwasser, J; Luo, X; O'Neill, K; Oelgeklaus, A; Schreiner, A; van der Laan, M; Zerbes, RM | 1 |
3 review(s) available for dactinomycin and cyclosporine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Multidrug resistant gene 1 product in human T cell subsets: role of protein kinase C isoforms and regulation by cyclosporin A.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cycloheximide; Cyclosporine; Dactinomycin; Drug Resistance; Gene Expression Regulation; Humans; Isoenzymes; Lymphocyte Activation; Membrane Glycoproteins; Mice; Models, Biological; Phytohemagglutinins; Protein Kinase C; T-Lymphocyte Subsets | 1992 |
A status report on drug-associated acne and acneiform eruptions.
Topics: Acne Vulgaris; Acneiform Eruptions; Adrenal Cortex Hormones; Cyclosporine; Dactinomycin; ErbB Receptors; Humans; Lithium Carbonate; Sirolimus; Tumor Necrosis Factor-alpha | 2010 |
1 trial(s) available for dactinomycin and cyclosporine
| Article | Year |
|---|---|
Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Cyclophosphamide; Cyclosporine; Dactinomycin; Drug Interactions; Etoposide; Fever; Humans; Ifosfamide; Immunosuppressive Agents; Neutropenia; Patient Admission; Retrospective Studies; Sarcoma; Sepsis; Soft Tissue Neoplasms; Vincristine | 1998 |
35 other study(ies) available for dactinomycin and cyclosporine
| Article | Year |
|---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Mechanisms of cytotoxicity used by human peripheral blood T-cell subsets.
Topics: Bucladesine; CD4 Antigens; CD8 Antigens; Cholera Toxin; Cycloheximide; Cyclosporine; Cytotoxicity, Immunologic; Dactinomycin; Egtazic Acid; Emetine; Humans; Lymphocyte Activation; Mitomycin; T-Lymphocyte Subsets; Tumor Necrosis Factor-alpha | 1992 |
Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Topics: Antigens, Differentiation, T-Lymphocyte; CD3 Complex; CD4-Positive T-Lymphocytes; CD8 Antigens; Cyclosporine; Cytotoxicity, Immunologic; Dactinomycin; Gene Expression; Granzymes; Humans; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Membrane Glycoproteins; Membrane Proteins; Mitomycin; Perforin; Pore Forming Cytotoxic Proteins; Protein Synthesis Inhibitors; Receptors, Antigen, T-Cell; Serine Endopeptidases; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; Tumor Necrosis Factor-alpha | 1992 |
Interleukin-4 (IL-4) receptor expression on human T cells is affected by different intracellular signaling pathways and by IL-4 at transcriptional and posttranscriptional level.
Topics: Calcimycin; Calcium; Cells, Cultured; Concanavalin A; Cycloheximide; Cyclosporine; Dactinomycin; Gene Expression Regulation; Humans; Interleukin-4; Receptors, Interleukin-4; Receptors, Mitogen; RNA Processing, Post-Transcriptional; RNA, Messenger; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription, Genetic | 1992 |
Interleukin-2-dependent phosphorylation of the retinoblastoma-susceptibility-gene product p110-115RB in human T-cells.
Topics: Cell Cycle; Cells, Cultured; Cyclosporine; Dactinomycin; Genes, Retinoblastoma; Humans; Interleukin-2; Lymphocyte Activation; Mitogens; Nuclear Proteins; Phosphorylation; Retinoblastoma Protein; Signal Transduction; Stimulation, Chemical; T-Lymphocytes | 1992 |
Modulation of anti-tumor cytotoxicity of cultured mast cells by metabolic inhibitors.
Topics: Animals; Cholera Toxin; Cyclosporine; Cytotoxicity, Immunologic; Dactinomycin; Immunity, Cellular; In Vitro Techniques; Mast Cells; Mice; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1992 |
Anti-IgM antibody-induced cell death in a human B lymphoma cell line, B104, represents a novel programmed cell death.
Topics: Antibodies, Anti-Idiotypic; Calcium; Cell Death; Cycloheximide; Cyclosporine; Dactinomycin; DNA; DNA Damage; Humans; Immunoglobulin M; Lymphoma, B-Cell; Tumor Cells, Cultured | 1992 |
Effect of combination of deoxypyridoxine with known anti-proliferative or immunosuppressive agents on lymphocyte serine hydroxymethyltransferase.
Topics: Antineoplastic Agents; Asparaginase; Cells, Cultured; Cyclosporine; Cytarabine; Dactinomycin; Glycine Hydroxymethyltransferase; Humans; Immunosuppressive Agents; Lymphocytes; Pyridoxine | 1994 |
Accumulation of sequence-specific RNA-binding proteins in the cytosol of activated T cells undergoing RNA degradation and apoptosis.
Topics: Alkaloids; Animals; Antibodies, Monoclonal; Apoptosis; Base Sequence; Blotting, Northern; Columbidae; Cyclosporine; Cytochrome c Group; Cytosol; Dactinomycin; Enzyme Inhibitors; Hybridomas; Interleukin-2; Lymphocyte Activation; Lymphokines; Molecular Sequence Data; Receptors, Antigen, T-Cell; Restriction Mapping; RNA; RNA Probes; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Staurosporine; T-Lymphocytes; Uridine | 1995 |
Long-term enhancement of Na,K-ATPase pump during blasttransformation of human lymphocytes is controlled first by translational, then by transcriptional mechanisms.
Topics: Cell Cycle; Cell Division; Cells, Cultured; Cyclosporine; Dactinomycin; Humans; Lymphocyte Activation; Lymphocytes; Phytohemagglutinins; Protein Biosynthesis; Sodium-Potassium-Exchanging ATPase; Transcription, Genetic | 1995 |
Differential modulation of P-glycoprotein transport by protein kinase inhibition.
Topics: Affinity Labels; Alkaloids; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biological Transport; Carrier Proteins; Cyclosporine; Dactinomycin; Dihydropyridines; Drug Resistance; Humans; Isoenzymes; Membrane Glycoproteins; Naphthalenes; Polycyclic Compounds; Protein Kinase C; Rhodamine 123; Rhodamines; Staurosporine; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Verapamil; Vinblastine; Vincristine | 1993 |
Enhanced toxicity of dactinomycin and vincristine by cyclosporine given to reverse multidrug resistance.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Dactinomycin; Drug Resistance; Humans; Male; Neoplasms; Vincristine | 1994 |
Immunosuppressant target protein FKBP12 is required for P-glycoprotein function in yeast.
Topics: Amino Acid Isomerases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcineurin; Calmodulin-Binding Proteins; Carrier Proteins; Cyclosporine; Dactinomycin; DNA-Binding Proteins; Drug Resistance, Multiple; Heat-Shock Proteins; Humans; Immunosuppressive Agents; Methyltransferases; Mice; Mutation; Peptidylprolyl Isomerase; Phosphoprotein Phosphatases; Plasmodium falciparum; Saccharomyces cerevisiae; Tacrolimus; Tacrolimus Binding Proteins | 1996 |
T cell receptor signals enhance susceptibility to Fas-mediated apoptosis.
Topics: Animals; Apoptosis; Calcium; Cyclosporine; Dactinomycin; DNA-Binding Proteins; Drug Synergism; Enzyme Activation; Fas Ligand Protein; fas Receptor; Hybridomas; Immunosuppressive Agents; Ionomycin; Ionophores; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Nuclear Receptor Subfamily 4, Group A, Member 1; Nucleic Acid Synthesis Inhibitors; Protein Kinase C; Receptors, Antigen, T-Cell; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Recombinant Fusion Proteins; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factors | 1997 |
Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-gamma.
Topics: Antibodies, Monoclonal; CD28 Antigens; CD3 Complex; CD4-Positive T-Lymphocytes; Cells, Cultured; Cyclosporine; Dactinomycin; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Interleukin-3; Interleukin-4; Interleukin-5; Interleukins; Kinetics; Nucleic Acid Synthesis Inhibitors; RNA, Messenger; Transcription, Genetic | 1998 |
Activation-induced down-regulation of retinoid receptor RXRalpha expression in human T lymphocytes. Role of cell cycle regulation.
Topics: Base Sequence; CD3 Complex; Cell Cycle; Cloning, Molecular; Cycloheximide; Cyclosporine; Dactinomycin; DNA Primers; Down-Regulation; Gene Expression Regulation; Humans; In Vitro Techniques; Lymphocyte Activation; Molecular Sequence Data; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; RNA, Messenger; T-Lymphocytes | 1998 |
Chronic rejection and chronic cyclosporin toxicity in renal allografts.
Topics: Animals; Blotting, Northern; Cell Line; Chronic Disease; Cyclosporine; Dactinomycin; Graft Rejection; Growth Substances; Humans; Immunosuppressive Agents; Kidney Transplantation; Nucleic Acid Synthesis Inhibitors; Rats; RNA, Messenger; Transforming Growth Factor beta | 1998 |
Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells.
Topics: 12E7 Antigen; Antibodies, Monoclonal; Antigens, CD; Apoptosis; Calcineurin; Calcium; Caspase Inhibitors; Caspases; Cell Adhesion Molecules; Cell Differentiation; Cyclosporine; Dactinomycin; Fluorescent Antibody Technique, Indirect; Humans; Membrane Potentials; Microscopy, Confocal; Microscopy, Electron; Neuroblastoma; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Tacrolimus; Tumor Cells, Cultured | 1998 |
Effect of Ca(2+) ATPase inhibitors on MCP-1 release from bone marrow-derived mast cells and the involvement of p38 MAP kinase activation.
Topics: Animals; Blotting, Western; Bone Marrow Cells; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Calcium-Transporting ATPases; Chemokine CCL2; Cyclosporine; Dactinomycin; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Female; Hydroquinones; Indoles; Mast Cells; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2000 |
Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Transfusion; Chi-Square Distribution; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Dactinomycin; Etoposide; Female; Fever; Humans; Ifosfamide; Male; Neutropenia; Pilot Projects; Platelet Transfusion; Retrospective Studies; Sarcoma; Sepsis; Treatment Outcome; Vincristine | 2000 |
Regulation of tumor necrosis factor cytotoxicity by calcineurin.
Topics: Animals; Apoptosis; Calcineurin; Caspases; Cell Death; Cyclosporine; Cytochrome c Group; Dactinomycin; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; Intracellular Membranes; L-Lactate Dehydrogenase; Mitochondria, Liver; Mitochondrial Swelling; Permeability; Rats; Rats, Sprague-Dawley; Tacrolimus; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
D-amino acid residues in peptides and proteins.
Topics: Amino Acids; Artifacts; Crystallography, X-Ray; Cyclosporine; Dactinomycin; Databases, Protein; Gramicidin; Melitten; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peptides; Protein Structure, Secondary; Proteins; Stereoisomerism | 2003 |
Mechanisms of apoptosis in human retinal pigment epithelium induced by TNF-alpha in conditions of heavy metal ion deficiency.
Topics: Apoptosis; Caspase 3; Caspases; Cell Line; Chelating Agents; Cyclosporine; Dactinomycin; Drug Combinations; Enzyme Activation; Ethylenediamines; Fluorescent Dyes; Humans; Ion Channels; Membrane Potentials; Metals, Heavy; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Pigment Epithelium of Eye; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2005 |
The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo.
Topics: Apoptosis; B-Lymphocytes; Cyclosporine; Dactinomycin; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Signal Transduction; T-Lymphocytes; Tacrolimus; Tumor Suppressor Protein p53 | 2006 |
Cardiac glycoside induces cell death via FasL by activating calcineurin and NF-AT, but apoptosis initially proceeds through activation of caspases.
Topics: Antibodies; Apoptosis; bcl-X Protein; Calcineurin; Calcineurin Inhibitors; Calcium; Cardenolides; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Nucleus; Cyclosporine; Dactinomycin; DNA; Enzyme Activation; Enzyme Inhibitors; Fas Ligand Protein; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Lipids; Membrane Fluidity; Necrosis; NFATC Transcription Factors; Oligopeptides; Protein Transport; Sodium-Potassium-Exchanging ATPase | 2007 |
Quantitative measure of cytotoxicity of anticancer drugs and other agents.
Topics: Antineoplastic Agents; Caffeine; Cell Death; Cell Respiration; Cyclosporine; Dactinomycin; Doxorubicin; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Jurkat Cells; Platinum Compounds; Tirapazamine; Triazines | 2008 |
c-Jun N-terminal kinase negatively regulates epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines.
Topics: Anthracenes; Calcineurin Inhibitors; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclooxygenase 2; Cyclosporine; Dactinomycin; Enzyme Inhibitors; Epidermal Growth Factor; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mouth Neoplasms; NFATC Transcription Factors; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Synthesis Inhibitors; Transcription, Genetic | 2009 |
Hexokinases inhibit death receptor-dependent apoptosis on the mitochondria.
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cell Line; Cyclosporine; Dactinomycin; Doxorubicin; Enzyme Inhibitors; Fas Ligand Protein; Gene Deletion; Gene Expression Regulation, Enzymologic; Hexokinase; Humans; Mitochondria; TNF-Related Apoptosis-Inducing Ligand | 2021 |